母嬰保健建議描述：：Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-037424  Size: 5 KB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-021603  Act: 34  Size: 7 MB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-037431  Size: 6 KB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 8-K Current report, items 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001193125-22-303275  Act: 34  Size: 10 MB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-037432  Size: 5 KB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-037435  Size: 5 KB 網頁鏈接 Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-22-308821  Act: 34  Size: 175 KB 網頁鏈接 牛唐： Magenta Therapeutics(MGTA) 又一個40%+的收益。拼多多(PDD)蔚來(NIO) Magenta Therapeutics(MGTA)： Magenta Therapeutics(MGTA) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-22-276477  Act: 34  Size: 209 KB 網頁鏈接